Enimmune corporation (6564.TWO)
TWD 18.95
(-26.41%)
TWD 18.95
(-26.41%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -228.96 Million TWD | 9.75% |
| 2022 | -258.42 Million TWD | -561.36% |
| 2021 | -38.39 Million TWD | 43.04% |
| 2020 | -67.29 Million TWD | -2.0% |
| 2019 | -50.72 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -35.19 Million TWD | 53.19% |
| 2024 Q2 | -44.37 Million TWD | -26.09% |
| 2023 Q1 | -42.75 Million TWD | 29.41% |
| 2023 Q3 | -75.18 Million TWD | -75.87% |
| 2023 FY | - TWD | 9.75% |
| 2023 Q4 | -75.18 Million TWD | 0.0% |
| 2023 Q2 | -42.75 Million TWD | 0.0% |
| 2022 Q3 | -60.56 Million TWD | 0.0% |
| 2022 FY | - TWD | -561.36% |
| 2022 Q4 | -60.56 Million TWD | 0.0% |
| 2021 FY | - TWD | 43.04% |
| 2020 FY | - TWD | -2.0% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -395.119% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 158.171% |
| Level Biotechnology Inc. | 98.7 Million TWD | 331.969% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -411.775% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -217.497% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -807.395% |
| GlycoNex Incorporation | -126.82 Million TWD | -80.532% |
| VBI | -6.97 Million TWD | -3184.036% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -59.34% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1149.807% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1191.679% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -120.975% |
| Visgeneer Inc. | 973 Thousand TWD | 23631.655% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 32.555% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 124.45% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 329.337% |
| Neith Corporation | -33.61 Million TWD | -581.235% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 76.898% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -13081.52% |
| TaiRx, Inc. | -208.64 Million TWD | -9.738% |
| CHO Pharma, Inc. | -277.73 Million TWD | 17.559% |
| EirGenix Inc. | -664.4 Million TWD | 65.539% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 409.811% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 431.144% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 78.63% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -102.432% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 757.222% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -267.275% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -770.582% |
| RBC Bioscience Corporation | 36.54 Million TWD | 726.489% |
| BiOptic Inc. | 65.03 Million TWD | 452.045% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 66.45% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -593.701% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -316.941% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 152.81% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -185.946% |
| NaviFUS Corp. | -55.79 Million TWD | -310.365% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1279.461% |
| Sinew Pharma Inc. | -163.63 Million TWD | -39.926% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -272.298% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 219.002% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -1.008% |
| AP Biosciences Inc | -325.51 Million TWD | 29.661% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 78.082% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -538.741% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 886.004% |
| Intech Biopharm Corporation | -219.58 Million TWD | -4.271% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 66.041% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -409.361% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -42.339% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 134.928% |
| TCI GENE Inc. | 25.98 Million TWD | 981.271% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -106.948% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 19.318% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -56.856% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1753.162% |
| PharmaEngine, Inc. | 347.3 Million TWD | 165.925% |
| Savior Lifetec Corporation | 219.6 Million TWD | 204.261% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 232.94% |
| OBI Pharma, Inc. | -855.08 Million TWD | 73.223% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -147.359% |
| Acepodia, Inc. | -764.51 Million TWD | 70.051% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 50.235% |